{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:10:47Z","timestamp":1792001447560,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T00:00:00Z","timestamp":1321488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1038\/hr.2011.189","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T07:10:10Z","timestamp":1321513810000},"page":"245-250","source":"Crossref","is-referenced-by-count":60,"title":["Sex-related differences in pharmacokinetics and pharmacodynamics of anti-hypertensive drugs"],"prefix":"10.1038","volume":"35","author":[{"given":"Koichi","family":"Ueno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,17]]},"reference":[{"key":"BFhr2011189_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(08)00001-9","volume":"83","author":"GD Anderson","year":"2008","unstructured":"Anderson GD . Gender differences in pharmacological response. Int Rev Neurobiol 2008; 83: 1\u201310.","journal-title":"Int Rev Neurobiol"},{"key":"BFhr2011189_CR2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/B978-012440905-7\/50346-7","volume-title":"Principles of Gender-Specific Medicine","author":"JB Schwartz","year":"2004","unstructured":"Schwartz JB . Drug metabolism. In Legato MJ (eds) Principles of Gender-Specific Medicine 2nd edn, Elsevier Academic Press: San Diego 2004, pp 825\u2013829."},{"key":"BFhr2011189_CR3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/152460902760360559","volume":"11","author":"M Anthony","year":"2002","unstructured":"Anthony M, Berg MJ . Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part I. Workshop held at the National Institute of Health, May 4\u20136, 1999. J Womens Health Gend Based Med 2002; 11: 601\u2013615.","journal-title":"J Womens Health Gend Based Med"},{"key":"BFhr2011189_CR4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/bdd.512","volume":"27","author":"S Dadashzadeh","year":"2006","unstructured":"Dadashzadeh S, Javadian B, Sadeghian S . The effect of gender on the pharmacokinetics of verapamil and norverapamil in human. Biopharm Drug Dispos 2006; 27: 329\u2013334.","journal-title":"Biopharm Drug Dispos"},{"key":"BFhr2011189_CR5","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/hep.1840380424","volume":"38","author":"R Wolbold","year":"2003","unstructured":"Wolbold R, Klein K, Burk O, N\u00fcssler AK, Neuhaus P, Eichelbaum M, Schwab M, Zanger UM . Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 2003; 38: 978\u2013988.","journal-title":"Hepatology"},{"key":"BFhr2011189_CR6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0006-2952(95)00192-3","volume":"50","author":"J George","year":"1995","unstructured":"George J, Byth K, Farrell GC . Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochem Pharmacol 1995; 50: 727\u2013730.","journal-title":"Biochem Pharmacol"},{"key":"BFhr2011189_CR7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/clpt.1990.164","volume":"48","author":"DL Schmucker","year":"1990","unstructured":"Schmucker DL, Woodhouse KW, Wang RK, Wynne H, James OF, McManus M, Kremers P . Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther 1990; 48: 365\u2013374.","journal-title":"Clin Pharmacol Ther"},{"key":"BFhr2011189_CR8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","volume":"270","author":"T Shimada","year":"1994","unstructured":"Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP . Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994; 270: 414\u2013423.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFhr2011189_CR9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1067\/mcp.2002.128388","volume":"72","author":"CL Cummins","year":"2002","unstructured":"Cummins CL, Wu C-Y, Benet LZ . Sex-related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P-glycoprotein. Clin Pharmacol Ther 2002; 72: 474\u2013489.","journal-title":"Clin Pharmacol Ther"},{"key":"BFhr2011189_CR10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1067\/mcp.2000.109356","volume":"68","author":"ME Krecic-Shepard","year":"2000","unstructured":"Krecic-Shepard ME, Barnas CR, Slimko J, Schwartz JB . Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil. Clin Pharmacol Ther 2000; 68: 286\u2013292.","journal-title":"Clin Pharmacol Ther"},{"key":"BFhr2011189_CR11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0009-9236(99)70052-4","volume":"66","author":"ME Krecic-Shepard","year":"1999","unstructured":"Krecic-Shepard ME, Barnas CR, Slimko J, Groski J, WainerI, Schwartz JB . In vivo comparison of putative probes of CYP3A4\/5 activity: erythromycin, dextromethorphan, and verapamil. Clin Pharmacol Ther 1999; 66: 40\u201350.","journal-title":"Clin Pharmacol Ther"},{"key":"BFhr2011189_CR12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0002-9149(97)89205-3","volume":"77","author":"RA Kloner","year":"1996","unstructured":"Kloner RA, Sowers JR, DiBona GF, Gaffney M, Wein M . and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. Am J Cardiol 1996; 77: 713\u2013722.","journal-title":"Am J Cardiol"},{"issue":"Suppl 7","key":"BFhr2011189_CR13","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1097\/00005344-198812007-00024","volume":"12","author":"B de Bruijn","year":"1988","unstructured":"de Bruijn B, Cocco G, Tyler HM . Multicenter placebo-controlled comparison of amlodipine and atenolol in mild to moderate hypertension. J Cardiovasc Pharmacol 1988; 12 (Suppl 7): S107\u2013S109.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 7","key":"BFhr2011189_CR14","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/00005344-198812007-00020","volume":"12","author":"AR Lorimer","year":"1988","unstructured":"Lorimer AR, Smedsrud T, Walker P, Tyler HM . Comparison of amlodipine and verapamil in the treatment of mild to moderate hypertension. J Cardiovasc Pharmacol 1988; 12 (Suppl 7): S89\u2013S93.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr2011189_CR15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.clpt.2005.09.007","volume":"79","author":"D Kang","year":"2006","unstructured":"Kang D, Verotta D, Schwartz JB . Population analyses of amlodipine in patients living in the community and patients living in nursing homes. Clin Pharmacol Ther 2006; 79: 114\u2013124.","journal-title":"Clin Pharmacol Ther"},{"key":"BFhr2011189_CR16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.clpt.2004.07.009","volume":"76","author":"DJ Greenblatt","year":"2004","unstructured":"Greenblatt DJ, Harmatz JS, von Moltke LL, Wright CE, Shader RI . Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate. Clin Pharmacol Ther 2004; 76: 467\u2013479.","journal-title":"Clin Pharmacol Ther"},{"key":"BFhr2011189_CR17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1139\/y05-012","volume":"83","author":"R Tatchum-Talom","year":"2005","unstructured":"Tatchum-Talom R, Eyster KM, Martin DS . Sexual dimorphism in angiotensin II-induced hypertension and vascular alterations. Can J Physiol Pharmacol 2005; 83: 413\u2013422.","journal-title":"Can J Physiol Pharmacol"},{"key":"BFhr2011189_CR18","doi-asserted-by":"crossref","first-page":"H2177","DOI":"10.1152\/ajpheart.00969.2004","volume":"288","author":"B Xue","year":"2005","unstructured":"Xue B, Pamidimukkala J, Hay M . Sex differences in the development of angiotensin II-induced hypertension in conscious mice. Am J Physiol Heart Circ Physiol 2005; 288: H2177\u2013H2184.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr2011189_CR19","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1172\/JCI114102","volume":"83","author":"KE Ellison","year":"1989","unstructured":"Ellison KE, Ingelfinger JR, Pivor M, Dzau VJ . Androgen regulation of rat renal angiotensinogen messenger RNA expression. J Clin Invest 1989; 83: 1941\u20131945.","journal-title":"J Clin Invest"},{"key":"BFhr2011189_CR20","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/HYPERTENSIONAHA.107.106922","volume":"51","author":"JC Sartori-Valinotti","year":"2008","unstructured":"Sartori-Valinotti JC, Iliescu R, Yanes LL, Dorsett-Martin W, Reckelhoff JF . Sex differences in the pressor response to angiotensin II when the endogenous renin-angiotensin system is blocked. Hypertension 2008; 51: 1170\u20131176.","journal-title":"Hypertension"},{"key":"BFhr2011189_CR21","doi-asserted-by":"crossref","first-page":"H1770","DOI":"10.1152\/ajpheart.01011.2005","volume":"292","author":"B Xue","year":"2007","unstructured":"Xue B, Pamidimukkala J, Lubahn DB, Hay M . Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induce hypertension in conscious female mice. Am J Physiol Heart Circ Physiol 2007; 292: H1770\u2013H1776.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr2011189_CR22","first-page":"662","volume":"67","author":"T Saruta","year":"2009","unstructured":"Saruta T . The contribution of ARB to medical treatment. Nippon Rinsho 2009; 67: 662\u2013667.","journal-title":"Nippon Rinsho"},{"key":"BFhr2011189_CR23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1358\/dot.2010.46.6.1487367","volume":"46","author":"H Suzuki","year":"2010","unstructured":"Suzuki H, Araki R . Cardiovascular outcome of an angiotensin II receptor blocker, candesartan, in Japan. Drugs Today (Barc) 2010; 46: 427\u2013431.","journal-title":"Drugs Today (Barc)"},{"key":"BFhr2011189_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1524-6175.2007.07195.x","volume":"10","author":"E Saunders","year":"2008","unstructured":"Saunders E, Cable G, Neutel J . Predictors of blood pressure response to angiotensin receptor blocker\/diuretic combination therapy: a secondary analysis of the irbesartan\/hydrochlorothiazide blood pressure reductions in diverse patient populations (INCLUSIVE) study. J Clin Hypertens (Greenwich) 2008; 10: 27\u201333.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"BFhr2011189_CR25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1385\/ENDO:28:2:199","volume":"28","author":"SM McBride","year":"2005","unstructured":"McBride SM, Flynn FW, Ren J . Cardiovascular alteration and treatment of hypertension: do men and women differ? Endocrine 2005; 28: 199\u2013207.","journal-title":"Endocrine"},{"key":"BFhr2011189_CR26","unstructured":"Bristol-Myers Squibb. AVAPRO and AVALIDE: Hypertension treatment. Full Prescribing Information for AVALIDE\u00ae (irbesartan-hydrochlorothiazide). http:\/\/packageinserts.bms.com\/pi\/pi_avalide.pdf (accessed 2 May 2011)."},{"key":"BFhr2011189_CR27","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1681\/ASN.2005101095","volume":"17","author":"JA Miller","year":"2006","unstructured":"Miller JA, Cherney DZ, Duncan JA, Lai V, Burns KD, Kennedy CR, Zimpelmann J, Gao W, Cattran DC, Scholey JW . Gender differences in the renal response to renin-angiotensin system blockade. J Am Soc Nephrol 2006; 17: 2554\u20132560.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr2011189_CR28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.clinthera.2008.04.013","volume":"30","author":"BM Everett","year":"2008","unstructured":"Everett BM, Glynn RJ, Danielson E, Ridker PM . Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial. Clin Ther 2008; 30: 661\u2013672.","journal-title":"Clin Ther"},{"key":"BFhr2011189_CR29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00005344-200405000-00018","volume":"43","author":"P Zapater","year":"2004","unstructured":"Zapater P, Novalbos J, Gallego-Sand\u00edn S, Hern\u00e1ndez FT, Abad-Santos F . Gender differences in angiotensin-converting enzyme (ACE) activity and inhibition by enalaprilat in healthy volunteers. J Cardiovasc Pharmacol 2004; 43: 737\u2013744.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFhr2011189_CR30","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/00004872-200406000-00023","volume":"22","author":"C lconnet","year":"2004","unstructured":"lconnet C, Bochud M, Bovet P, Maillard M, Burnier M . Gender difference in the response to an angiotensin-converting enzyme inhibitor and a diuretic in hypertensive patients of African descent. J Hypertens 2004; 22: 1213\u20131220.","journal-title":"J Hypertens"},{"key":"BFhr2011189_CR31","doi-asserted-by":"crossref","first-page":"R1220","DOI":"10.1152\/ajpregu.00864.2007","volume":"294","author":"JC Sullivan","year":"2008","unstructured":"Sullivan JC . Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition. Am J Physiol Regul Integr Comp Physiol 2008; 294: R1220\u2013R1226.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFhr2011189_CR32","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/01.ATV.0000186185.13977.94","volume":"25","author":"M Pretorius","year":"2005","unstructured":"Pretorius M, Luther JM, Murphey LJ, Vaughan DE, Brown NJ . Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men. Arterioscler Thromb Vasc Biol 2005; 25: 2435\u20132440.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFhr2011189_CR33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00003088-200847050-00003","volume":"47","author":"D Werner","year":"2008","unstructured":"Werner D, Werner U, Meybaum A, Schmidt B, Umbreen S, Grosch A, Lestin HG, Graf B, Zolk O, Fromm MF . Determinants of steady-state torasemide pharmacokinetics: impact of pharmacogenetic factors, gender and angiotensin II receptor blockers. Clin Pharmacokinet 2008; 47: 323\u2013332.","journal-title":"Clin Pharmacokinet"},{"key":"BFhr2011189_CR34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/phrs.2001.0912","volume":"45","author":"JA Cerrutti","year":"2002","unstructured":"Cerrutti JA, Quaglia NB, Brandoni A, Torres AM . Effects of gender on the pharmacokinetics of drugs secreted by the renal organic anions transport systems in the rat. Pharmacol Res 2002; 45: 107\u2013112.","journal-title":"Pharmacol Res"},{"key":"BFhr2011189_CR35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00003088-200342020-00001","volume":"42","author":"JB Schwartz","year":"2003","unstructured":"Schwartz JB . The influence of sex on pharmacokinetics. Clin Pharmacokinet 2003; 42: 107\u2013121.","journal-title":"Clin Pharmacokinet"},{"key":"BFhr2011189_CR36","first-page":"219","volume":"2","author":"A Fletcher","year":"1988","unstructured":"Fletcher A, Beevers DG, Bulpitt C, Butler A, Coles EC, Hunt D, Munro-Faure AD, Newson RB, O\u2019Riordan PW, Petrie JC . Beta adrenoceptor blockade is associated with increased survival in male but not female hypertensive patients: a report from the DHSS Hypertension Care Computing Project (DHCCP). J Hum Hypertens 1988; 2: 219\u2013227.","journal-title":"J Hum Hypertens"},{"key":"BFhr2011189_CR37","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","volume":"247","author":"\u03b2-Blocker Heart Attack Trial Research Group","year":"1982","unstructured":"\u03b2-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982; 247: 1707\u20131714.","journal-title":"JAMA"},{"key":"BFhr2011189_CR38","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/cp.1999.v66.103400001","volume":"66","author":"AB Luzier","year":"1999","unstructured":"Luzier AB, Killian A, Wilton JH, Wilson MF, Forrest A, Kazierad DJ . Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Clin Pharmacol Ther 1999; 66: 594\u2013601.","journal-title":"Clin Pharmacol Ther"},{"key":"BFhr2011189_CR39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000092769","volume":"106","author":"G Cocco","year":"2006","unstructured":"Cocco G, Chu D . The anti-ischemic effect of metoprolol in patients with chronic angina pectoris is gender-specific. Cardiology 2006; 106: 147\u2013153.","journal-title":"Cardiology"},{"key":"BFhr2011189_CR40","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/clpt.1983.242","volume":"34","author":"MS Lennard","year":"1983","unstructured":"Lennard MS, Tucker GT, Silas JH, Freestone S, Ramsay LE, Woods HF . Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers. Clin Pharmacol Ther 1983; 34: 732\u2013737.","journal-title":"Clin Pharmacol Ther"},{"key":"BFhr2011189_CR41","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1067\/mcp.2000.106464","volume":"67","author":"BA Hamelin","year":"2000","unstructured":"Hamelin BA, Bouayad A, M\u00e9thot J, Jobin J, Desgagn\u00e9s P, Poirier P, Allaire J, Dumesnil J, Turgeon J . Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity. Clin Pharmacol Ther 2000; 67: 466\u2013477.","journal-title":"Clin Pharmacol Ther"},{"key":"BFhr2011189_CR42","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1124\/jpet.104.081109","volume":"313","author":"A Sharma","year":"2005","unstructured":"Sharma A, Pibarot P, Pilote S, Dumesnil JG, Arsenault M, B\u00e9langer PM, Meibohm B, Hamelin BA . Modulation of metoprolol pharmacokinetics and hemodynamics by diphenhydramine coadministration during exercise testing in healthy premenopausal women. J Pharmacol Exp Ther 2005; 313: 1172\u20131181.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFhr2011189_CR43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/0091270009340417","volume":"50","author":"A Sharma","year":"2010","unstructured":"Sharma A, Pibarot P, Pilote S, Dumesnil JG, Arsenault M, B\u00e9langer PM, Meibohm B, Hamelin BA . Toward optimal treatment in women: the effect of sex on metoprolol-diphenhydramine interaction. J Clin Pharmacol 2010; 50: 214\u2013225.","journal-title":"J Clin Pharmacol"},{"key":"BFhr2011189_CR44","first-page":"468","volume":"16","author":"HG Xie","year":"1995","unstructured":"Xie HG, Chen X . Sex differences in pharmacokinetics of oral propranolol in healthy Chinese volunteers. Zhongguo Yao Li Xue Bao 1995; 16: 468\u2013470.","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"BFhr2011189_CR45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/clpt.1989.136","volume":"46","author":"T Walle","year":"1989","unstructured":"Walle T, Walle UK, Cowart TD, Conradi EC . Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects. Clin Pharmacol Ther 1989; 46: 257\u2013263.","journal-title":"Clin Pharmacol Ther"},{"key":"BFhr2011189_CR46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/clpt.1994.115","volume":"56","author":"T Walle","year":"1994","unstructured":"Walle T, Walle K, Mathur RS, Palesch YY, Conradi EC . Propranolol metabolism in normal subjects: association with sex steroid hormones. Clin Pharmacol Ther 1994; 56: 127\u2013132.","journal-title":"Clin Pharmacol Ther"},{"key":"BFhr2011189_CR47","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00228-006-0138-7","volume":"62","author":"N Baris","year":"2006","unstructured":"Baris N, Kalkan S, G\u00fcneri S, Bozdemir V, Guven H . Influence of carvedilol on serum digoxin levels in heart failure: is there any gender difference? Eur J Clin Pharmacol 2006; 62: 535\u2013538.","journal-title":"Eur J Clin Pharmacol"},{"key":"BFhr2011189_CR48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-200241050-00002","volume":"41","author":"B Meibohm","year":"2002","unstructured":"Meibohm B, Beierle I, Derendorf H . How important are gender differences in pharmacokinetics? Clin Pharmacokinet 2002; 41: 329\u2013342.","journal-title":"Clin Pharmacokinet"},{"key":"BFhr2011189_CR49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1248\/bpb.28.114","volume":"28","author":"T Aiba","year":"2005","unstructured":"Aiba T, Ishida K, Yoshinaga M, Okuno M, Hashimoto Y . Pharmacokinetic characterization of transcellular transport and drug interaction of digoxin in Caco-2 cell monolayers. Biol Pharm Bull 2005; 28: 114\u2013119.","journal-title":"Biol Pharm Bull"},{"key":"BFhr2011189_CR50","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0024-3205(01)01494-1","volume":"70","author":"K Takara","year":"2002","unstructured":"Takara K, Kakumoto M, Tanigawara Y, Funakoshi J, Sakaeda T, Okumura K . Interaction of digoxin with antihypertensive drugs via MDR1. Life Sci 2002; 70: 1491\u20131500.","journal-title":"Life Sci"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2011189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2011189","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2011189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T04:43:51Z","timestamp":1741927431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2011189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,17]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["BFhr2011189"],"URL":"https:\/\/doi.org\/10.1038\/hr.2011.189","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,17]]}}}